Home » Schizophrenia Research » Your Schizophrenia Medication may not be the best medicine

Your Schizophrenia Medication may not be the best medicine

Medical News Today recently published an article on March 22nd, 2012, which was revealed in PLoS Medicine that tested the effect of medical journals on the perception of 2nd generation anti-psychotic drugs by psychiatrists. The researchers believed that the medical journals were embellishing the effectiveness of these new drugs, thereby influencing the psychiatrists to prescribe them more often. According to their research, their results were very similar to their previous thoughts:

  • Out of 24 FDA-registered pre-marketing trials for 8 second generation anti-psychotics, 4 displayed negative pre-marketing trial results and were never published
  •  Additionally, one was statistically inferior to its competitor drugs, yet the medical journal did not print this information in the article
  • Above all, 3 pre-marking trials were not tested to be more beneficial than even a placebo medication

Lesson of the article: You may want to look into the trial results of your anti-psychotic medication to make sure you are prescribed the best medicine



Related Posts in Schizophrenia Research

Google+

Quick Information Inquiry:

Because Important Questions Require Precise Answers

Precise Research is committed to precise results. Our staff and participants work on the cutting edge of clinical research. Precise Research Centers is located in Jackson Mississippi and we participate in in regional, national, and international research studies.

We encourage you to fill out the form above to be contacted by one of our specialized research staff members.

Remember: by participating in one of our studies or clinical research trials, you'll be helping science take the necessary steps towards finding answers for others in the future!


Precise Research Serves the Central Mississippi region including Brandon, Madison, Ridgeland, Jackson Mississippi, Clinton in Madison & Rankin Counties MS.